Effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea: A pilot randomized trial
Physiological Reports · 2024
DOI: 10.14814/phy2.15948 ↗At a glance
Randomisierte kontrollierte Studie in Physiological Reports, 2024. Written by Elizabeth R M Zunica and 9 co-authors. Institution: Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA. Major MEDLINE topics: Metformin, Diabetes Mellitus, Sleep Apnea, Obstructive. Cited 5 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH HHS, NIDDK NIH HHS, NIA NIH HHS.
Abstract (original language)
Obstructive sleep apnea (OSA) is associated with increased risk for diabetes, and standard treatment with positive airway pressure (PAP) device shows inconsistent effects on glucose metabolism. Metformin is known to treat and prevent diabetes, but its effects on skeletal muscle mitochondrial function are not completely understood. Here, we evaluate the effects of metformin on glucose metabolism and skeletal muscle mitochondrial function in patients with OSA. Sixteen adults with obesity (50.9 ± 6.7 years, BMI: 36.5 ± 2.9 kg/m 2 ) and moderate‐to‐severe OSA were provided with PAP treatment and randomized to 3 months of placebo ( n = 8) or metformin ( n = 8) treatment in a double‐blind parallel‐group design. Whole body glucose metabolism was determined by oral glucose tolerance test. A skeletal muscle biopsy was obtained to evaluate mitochondrial respiratory capacity and expression of proteins related to mitochondrial dynamics and energy metabolism. Whole body insulin‐sensitivity (Matsuda index) did not change in metformin or placebo treated groups. However, metformin treatment prevented increases in insulin release relative to placebo during follow‐up. Insulin area under the curve (AUC) and insulin to glucose AUC ratio increased in placebo but remained unchanged with metformin. Furthermore, metformin treatment improved skeletal muscle mitochondrial respiratory capacity and dynamics relative to placebo. Metformin treatment prevented the decline in whole body glucose homeostasis and skeletal muscle mitochondrial function in patients with moderate to severe OSA. Patients with OSA may benefit from the addition of metformin to prevent diabetes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
- Translational Physiology Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
- Sleep and Cardiometabolic Health Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
- Louisiana State University Health Science Center, New Orleans, Louisiana, USA.
ORCID profiles: Elizabeth R M Zunica, John P Kirwan, Prachi Singh
Funding
- NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- NIGMS NIH HHS
- NCCIH NIH HHS
- National Institutes of Health
Cite
APA
Zunica, E. R. M., Heintz, E. C., Dantas, W. S., Hebert, R. C., Tanksley, M., Beyl, R. A., Mader, E. C., Kirwan, J. P., Axelrod, C. L., & Singh, P. (2024). Effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea: A pilot randomized trial. Physiological Reports. https://doi.org/10.14814/phy2.15948
Vancouver
Zunica ERM, Heintz EC, Dantas WS, Hebert RC, Tanksley M, Beyl RA, et al. Effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea: A pilot randomized trial. Physiological Reports. 2024. doi:10.14814/phy2.15948
BibTeX
@article{Zunica2024,
author = {Zunica, Elizabeth R M and Heintz, Elizabeth C and Dantas, Wagner S and Hebert, R Caitlin and Tanksley, MaKayla and Beyl, Robbie A and Mader, Edward C and Kirwan, John P and Axelrod, Christopher L and Singh, Prachi},
title = {Effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea: A pilot randomized trial},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.15948}
}
EUVIMED